◆英語タイトル：US Physical Therapy Inc (USPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C10119
◆発行会社（調査会社）：
GlobalData
◆発行日：2018年11月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of injured workers and neurological-related injuries, as well as rehabilitation of injured workers. It also manages physical therapy facilities for unaffiliated third parties and offers onsite services for clients’ employees including rehabilitation, injury prevention, ergonomic assessments and performance optimization. USPh provides its services through orthopedic surgeons, internal medicine physicians, podiatrists, neurosurgeons, physiatrists, occupational medicine physicians and general practitioners. It operates across the US through a network of subsidiaries. USPh is headquartered at Houston, Texas, the US.
US Physical Therapy Inc (USPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
US Physical Therapy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
U.S. Physical Therapy Acquires 70% Stake in Physical Therapy Practice for USD4.8 Million 9
Physical Therapy Acquires Three Clinic Physical Therapy Practice 10
U.S. Physical Therapy Acquires 70% Stake In 13 Clinic Physical Therapy Practice For US$11 Million 11
U.S. Physical Therapy Acquires 80% Stake In Five Clinic Physical Therapy Group 12
U.S. Physical Therapy Acquires 50% Stake In Five Clinic Physical Therapy Practice 13
U.S. Physical Therapy Acquires 72% Stake In Nine Clinic Physical Therapy Group For US$4 Million 14
U.S. Physical Therapy Acquires 70% Stake In Seven Clinic Physical Therapy Group For US$6.3 Million 15
Asset Transactions 16
U.S. Physical Therapy Sells Remaining Stake In Physician Services Business 16
Acquisition 17
U.S. Physical Therapy Acquires 60% Stake In Atlanta Falcons Physical Therapy Centers For US$1.7 Million 17
US Physical Therapy Inc – Key Competitors 18
US Physical Therapy Inc – Key Employees 19
US Physical Therapy Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Nov 01, 2018: U.S. Physical Therapy reports quarterly and nine months operating results 22
Aug 02, 2018: U.S. Physical Therapy reports record quarterly and six months operating results 25
May 03, 2018: U.S. Physical Therapy Reports First Quarter 2018 Results 28
Mar 08, 2018: U.S. Physical Therapy Reports Year-End 2017 Earnings 30
Nov 02, 2017: U.S. Physical Therapy Reports Third Quarter and Nine Months 2017 Results 33
Aug 03, 2017: U.S. Physical Therapy Reports Second Quarter and Six Months 2017 Results 37
Jun 29, 2017: U.S. Physical Therapy Reports First Quarter Results 39
Jun 07, 2017: U.S. Physical Therapy Reports 2016 Results 40
May 10, 2017: U.S. Physical Therapy Announces First Quarter 2017 Select Preliminary Operating and Financial Results 43
Corporate Communications 44
Mar 02, 2018: U.S. Physical Therapy Adds to Executive Team 44
Legal and Regulatory 45
Apr 14, 2017: U.S. PHYSICAL THERAPY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti Investigates the Officers and Directors of U.S. Physical Therapy – USPH 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
US Physical Therapy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
U.S. Physical Therapy Acquires 70% Stake in Physical Therapy Practice for USD4.8 Million 9
Physical Therapy Acquires Three Clinic Physical Therapy Practice 10
U.S. Physical Therapy Acquires 70% Stake In 13 Clinic Physical Therapy Practice For US$11 Million 11
U.S. Physical Therapy Acquires 80% Stake In Five Clinic Physical Therapy Group 12
U.S. Physical Therapy Acquires 50% Stake In Five Clinic Physical Therapy Practice 13
U.S. Physical Therapy Acquires 72% Stake In Nine Clinic Physical Therapy Group For US$4 Million 14
U.S. Physical Therapy Acquires 70% Stake In Seven Clinic Physical Therapy Group For US$6.3 Million 15
U.S. Physical Therapy Sells Remaining Stake In Physician Services Business 16
U.S. Physical Therapy Acquires 60% Stake In Atlanta Falcons Physical Therapy Centers For US$1.7 Million 17
US Physical Therapy Inc, Key Competitors 18
US Physical Therapy Inc, Key Employees 19
US Physical Therapy Inc, Subsidiaries 20
List of Figures
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
US Physical Therapy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
